New Zealand restricts access to puberty blockers for transgender youth

The New Zealand government has announced restrictions on the prescription of puberty-blocking drugs for transgender youth. Critics argue the move will negatively impact the mental health and well-being of transgender and gender-diverse young people.

Health Minister Simeon Brown stated that healthcare professionals will no longer be permitted to initiate new prescriptions of gonadotropin-releasing hormone analogues for gender dysphoria or incongruence. This restriction applies to people seeking treatment for these conditions who are not already receiving the medication.

The Guardian reports that the decision follows a health ministry review that cited a lack of "high-quality evidence that demonstrates the benefits or risks" associated with the use of puberty blockers in this context, according to Minister Brown. The ban is scheduled to take effect on December 19.

While other countries, such as the United Kingdom, have implemented similar temporary restrictions on the use of these drugs for individuals under 18 who are not currently taking them, the medications will continue to be available in New Zealand for treatment of early-onset puberty, endometriosis, and prostate cancer, as well as for existing users.

According to health ministry data, 113 individuals were receiving puberty blockers in 2023, a decrease from 140 in 2021.

Elizabeth McElrea, Vice-President of the Professional Association for Transgender Health Aotearoa, expressed deep concern about the potential consequences of the ban. "This ban will lead to worsening mental health, increased suicidality, and dysphoria for gender-diverse children and young people," McElrea stated. She also warned of a heightened risk of marginalization and discrimination for this vulnerable population.

Shanan Halbert, spokesperson for the Labour Party on rainbow issues, emphasized that treatment decisions should be made collaboratively by doctors, young people, and their parents. He also urged the government to provide adequate support for those affected by the ban.

Ricardo Menéndez March, a Member of Parliament from the Green Party, criticized the government's decision, suggesting it was influenced by external cultural conflicts. "The government should focus on addressing the core issues that our health system faces…rather than waging culture wars on trans people," he stated.